AB
COLL icon

Amalgamated Bank’s Collegium Pharmaceutical COLL Stock Holding History

Amalgamated Bank’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$311K Sell
8,587
-507
-6% -$17.3K ﹤0.01% 1490
2026
Q1 		$301K Sell
9,094
-56
-0.6% -$2.37K ﹤0.01% 1468
2025
Q4 		$424K Sell
9,150
-90
-1% -$3.77K ﹤0.01% 1376
2025
Q3 		$323K Buy
9,240
+4
+0% +$139 ﹤0.01% 1444
2025
Q2 		$273K Sell
9,236
-51
-0.5% -$1.46K ﹤0.01% 1470
2025
Q1 		$277K Sell
9,287
-244
-3% -$7.46K ﹤0.01% 1452
2024
Q4 		$273K Sell
9,531
-86
-0.9% -$2.85K ﹤0.01% 1492
2024
Q3 		$372K Sell
9,617
-418
-4% -$14.9K ﹤0.01% 1408
2024
Q2 		$323K Sell
10,035
-48
-0.5% -$1.66K ﹤0.01% 1450
2024
Q1 		$391K Sell
10,083
-3,787
-27% -$132K ﹤0.01% 1403
2023
Q4 		$427K Sell
13,870
-2,101
-13% -$52.6K ﹤0.01% 1501
2023
Q3 		$357K Buy
15,971
+180
+1% +$4.11K ﹤0.01% 1565
2023
Q2 		$339K Buy
15,791
+509
+3% +$11.6K ﹤0.01% 1612
2023
Q1 		$367K Sell
15,282
-1,087
-7% -$28.8K ﹤0.01% 1558
2022
Q4 		$380K Sell
16,369
-175
-1% -$3.53K ﹤0.01% 1589
2022
Q3 		$265K Buy
16,544
+146
+0.9% +$2.58K ﹤0.01% 1734
2022
Q2 		$291K Sell
16,398
-451
-3% -$7.59K ﹤0.01% 1707
2022
Q1 		$343K Sell
16,849
-1,098
-6% -$20.7K ﹤0.01% 1713
2021
Q4 		$335K Sell
17,947
-670
-4% -$13.1K ﹤0.01% 1763
2021
Q3 		$367K Sell
18,617
-316
-2% -$6.83K ﹤0.01% 1745
2021
Q2 		$448K Buy
+18,933
New +$437K ﹤0.01% 1698

Other funds holding COLL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
PCM
Peregrine Capital Management Minneapolis, Minnesota $3.08B AUM 29.51% 1-Year Est. Return
Universal-Beteiligungs- und Servicegesellschaft
Universal-Beteiligungs- und Servicegesellschaft Frankfurt Am Main, Germany $65.4B AUM 39.83% 1-Year Est. Return

Amalgamated Bank's COLL Position: Q2 2026 in Review

Amalgamated Bank reduced its Collegium Pharmaceutical (COLL) stake by 5.6% in Q2 2026, selling an estimated $17.3K and leaving 8,587 shares worth $311K. The position accounts for ﹤0.01% of the portfolio, ranked #1490.

Amalgamated Bank first reported a position in COLL in Q2 2021 and has held it in 21 quarters since. The position peaked at $448K in Q2 2021. 112 funds tracked by Wall St. Rank hold COLL as of Q2 2026.

  • Amalgamated Bank held 8,587 shares of Collegium Pharmaceutical worth $311K as of Q2 2026.
  • Amalgamated Bank sold 507 Collegium Pharmaceutical shares in Q2 2026, an estimated $17.3K.
  • Collegium Pharmaceutical made up ﹤0.01% of Amalgamated Bank's portfolio in Q2 2026, its #1490 holding.
  • Amalgamated Bank first reported a position in Collegium Pharmaceutical in Q2 2021 and has held it in 21 quarters since.
  • Amalgamated Bank's Collegium Pharmaceutical position peaked at $448K in Q2 2021.
  • 112 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q2 2026.

Based on Amalgamated Bank's 13F filing for Q2 2026, filed 23 Jul 2026.